72% of target number recruited
Active participation rate 93%, sample return rate 97%, Survey return rate 98%
717 patients recruited to the study
- CD: 245 (55 paediatric)
- UC: 201 (23 paediatric)
- Controls: 272 (26 paediatric)
Active participation rate 93%, sample return rate 97%, Survey return rate 98%
717 patients recruited to the study
Inflammatory bowel disease (IBD), comprising the 2 main forms – Crohn’s disease and ulcerative colitis, is a global disease challenge. It affects approximately 1 in 250 Australians, with over 80,000 Australians currently living with IBD. IBD arises from a dysregulated immune response to alterations in the gut microbiota in susceptible individuals. Sufferers can endure numerous attacks or ‘flares’ followed by periods of relative remission; however, the disease trigger remains elusive.
Being able to identify people at risk of IBD prior to symptoms, preventing symptom progression, and being able to define how patients are likely to respond to treatment, plays to the heart of IBD healthcare, namely, to improve patient health.
The Sydney+ IBD Research consortium was initiated in 2018 to bring together clinicians and researchers to improve IBD patient care. The consortium is an active collaboration comprising early, mid and advanced-career clinicians/scientists with complementary strengths. The first aim of the network was to develop the infrastructure to ensure a unified approach to patient recruitment/sample collection – an issue which hampers many multi-centre studies.
The Australian IBD Microbiome (AIM) Study is the inaugural study of the consortia and commenced recruitment in June 2019. The AIM study is a longitudinal cohort study with clinical data, patient-reported outcomes data, and biological samples collected from participants over a 24-month period.
The project will deliver:
June 2019
February 2025
Professor Georgina Hold
St George Hospital, Kogarah, NSW 2017
New South Wales
St Vincent’s Hospital
Royal Prince Alfred Hospital
Liverpool Hospital
Concord Hospital
Sydney Children’s Hospital, Randwick
Sydney Children’s Hospital, Westmead
Wollongong Hospital
Blacktown Hospital
Sutherland Hospital
Canberra Hospital
Queen Elizabeth Hospital, Adelaide
The AIM study receives or has received funds and or support from the following organisations:
Gastroenterological Society of Australia (GESA)
Crohn’s Colitis Australia (CCA)
St George and Sutherland Medical Research Foundation (SSMRF)
Bioanalytical Mass Spectrometry Facility.
Mark Wainwright Analytical Centre, UNSW
AIM Study Lead Ph: 91131855 |
|
Dr Betty Nan Wu AIM Study PhD student (CCA funded) Ph: 95240229 |
|
Associate Professor Daniel Avi Lemberg Lead Clinician – Sydney Children’s Hospital (Randwick) Ph: 91914959 |
|
Dr Gabrielle Wark Clinician – St Vincent’s Hospital Email: Gabrielle.Wark@svha.org.au |
|
Lead Clinician – St George Hospital Ph: 91131855 |
|
Professor Golo Ahlenstiel Clinician – Blacktown Hospital Ph: 9851 6073 |
|
Dr Sudarshan Paramsothy Clinician – Concord Hospital Ph: 97676111 |
|
Nutritionist – Garvan Institute of Medical Research Email: d.samochabonet@garvan.org.au |
|
Dr Astrid-Jane Williams Clinician – Liverpool Hospital |
|
Dr Crispin Corte Lead Clinician – Royal Prince Alfred Hospital Ph: 95158578 |
|
Lead Clinician – St Vincent’s Hospital Ph: 02 8382 6622 |
|
Senior Research Scientist, Bioanalytical Mass Spectrometry Facility, Mark Wainwright Analytical Centre, UNSW Ph: +61 2 9385 1678 |
|
Study Lead/ Microbiome Scientist – Sydney Children’s Hospital (Randwick) Ph: 938201883 |
|
Microbiome Scientist – University of Technology, Sydney Email: Catherine.Burke@uts.edu.au |
|
Dr Claire O'Brien Microbiome Scientist – University of Wollongong Ph: 02 6244 4023 |
|
Dr Viraj Kariyawasam Lead Clinician – Blacktown Hospital Ph: 02 8670 0086 |
|
Dr Craig Haifer Clinician – St Vincent’s Hospital Ph: 283810061 |
|
Lead Clinician – Concord Hospital |
|
Associate Professor Susan Connor Lead Clinician – Liverpool Hospital Ph: 61287384085 |
|
Clinical Associate Professor Thomas Lee Lead Clinician – Wollongong Hospital Ph: 02 4222 5180 |
|
Dr Paris Tavakoli Recruitment Lead – St Vincent’s Hospital Ph: 04242 52436 |
|
Dr Kelly Lambert Nutritionist – University of Wollongong Email: klambert@uow.edu.au |
|
Dr Ramesh Paramsothy Clinician - Blacktown Hospital
|
|
|
Dr Nerissa Bowcock Microbiome Scientist – Sydney Children’s Hospital (Randwick) Email: n.bowcock@unsw.edu.au
|
Dr Amanda Shapiro Recruitment lead and Microbiome scientist - SCH Randwick Email: a.shapiro@unsw.edu.au |
We are seeking research participants to learn about the changes in the human microbiota in inflammatory bowel disease (IBD). If we can determine how to prevent or treat disease, then we have the potential to positively change health outcomes for many future generations. Find out more by clicking on the link below.